JP2022521233A5 - - Google Patents
Info
- Publication number
- JP2022521233A5 JP2022521233A5 JP2021548664A JP2021548664A JP2022521233A5 JP 2022521233 A5 JP2022521233 A5 JP 2022521233A5 JP 2021548664 A JP2021548664 A JP 2021548664A JP 2021548664 A JP2021548664 A JP 2021548664A JP 2022521233 A5 JP2022521233 A5 JP 2022521233A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- administering
- age
- glyceryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810055P | 2019-02-25 | 2019-02-25 | |
| US62/810,055 | 2019-02-25 | ||
| PCT/US2020/019568 WO2020176432A1 (en) | 2019-02-25 | 2020-02-25 | Compositions including cinnamic acid and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521233A JP2022521233A (ja) | 2022-04-06 |
| JP2022521233A5 true JP2022521233A5 (enExample) | 2023-03-07 |
Family
ID=72238701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548664A Withdrawn JP2022521233A (ja) | 2019-02-25 | 2020-02-25 | 桂皮酸を含む組成物及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12478598B2 (enExample) |
| EP (1) | EP3930704A4 (enExample) |
| JP (1) | JP2022521233A (enExample) |
| KR (1) | KR20210130772A (enExample) |
| CN (1) | CN113473981A (enExample) |
| AU (1) | AU2020229316A1 (enExample) |
| CA (1) | CA3130761A1 (enExample) |
| EA (1) | EA202192199A1 (enExample) |
| WO (1) | WO2020176432A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202002639D0 (en) * | 2020-02-25 | 2020-04-08 | Ucl Business Ltd | Therapy |
| CN116390761A (zh) * | 2020-10-28 | 2023-07-04 | 拉什大学医学中心 | 肉桂酸苄酯组合物在治疗甘氨酸脑病和尿素循环障碍中的应用 |
| EP4440554A4 (en) * | 2021-12-01 | 2025-10-29 | Goldlake Lifesciences Pvt Ltd | PHARMACEUTICAL FORMULATION AND ITS PREPARATION PROCESS |
| CA3241282A1 (en) * | 2021-12-16 | 2023-06-22 | Kalipada PAHAN | Benzoic acid salts for treatment of nervous system injuries and disorders |
| WO2024201533A1 (en) * | 2023-03-31 | 2024-10-03 | Sava Healthcare Limited | A parenteral composition of cinnamic acid |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100479405B1 (ko) * | 2002-05-24 | 2005-03-30 | 주식회사 싸이제닉 | 신남산 이합체, 그 제조방법 및 퇴행성 뇌질환 치료를위한 그의 용도 |
| JP6836905B2 (ja) * | 2014-01-17 | 2021-03-03 | ラッシュ・ユニバーシティ・メディカル・センター | 尿素サイクル障害及び神経変性障害におけるベンゾエート含有組成物の使用 |
| ES2799309T3 (es) * | 2014-09-29 | 2020-12-16 | Cellix Bio Private Ltd | Compuestos y composiciones para el tratamiento de esclerosis múltiple |
| CN107205976A (zh) * | 2014-11-19 | 2017-09-26 | 拉什大学医学中心 | 用于治疗溶酶体病症的组合物和方法 |
| US11008277B2 (en) | 2016-06-13 | 2021-05-18 | Syneurx International (Taiwan) Corp. | Co-crystals of sodium benzoate and uses thereof |
| EP3691630A4 (en) * | 2017-10-06 | 2021-10-27 | Rush University Medical Center | USE OF A COMPOSITION CONTAINING BENZOATE TO TREAT GLYCINE ENCEPHALOPATHY |
| GB202002639D0 (en) | 2020-02-25 | 2020-04-08 | Ucl Business Ltd | Therapy |
| CN116390761A (zh) * | 2020-10-28 | 2023-07-04 | 拉什大学医学中心 | 肉桂酸苄酯组合物在治疗甘氨酸脑病和尿素循环障碍中的应用 |
| EP4281118A4 (en) * | 2021-01-20 | 2025-01-01 | Rush University Medical Center | Improved treatment for globoid cell leukodsytrophy or krabbe disease |
-
2020
- 2020-02-25 WO PCT/US2020/019568 patent/WO2020176432A1/en not_active Ceased
- 2020-02-25 CN CN202080016447.1A patent/CN113473981A/zh active Pending
- 2020-02-25 EA EA202192199A patent/EA202192199A1/ru unknown
- 2020-02-25 JP JP2021548664A patent/JP2022521233A/ja not_active Withdrawn
- 2020-02-25 AU AU2020229316A patent/AU2020229316A1/en not_active Abandoned
- 2020-02-25 CA CA3130761A patent/CA3130761A1/en active Pending
- 2020-02-25 US US17/433,730 patent/US12478598B2/en active Active
- 2020-02-25 KR KR1020217030331A patent/KR20210130772A/ko not_active Withdrawn
- 2020-02-25 EP EP20763119.3A patent/EP3930704A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521233A5 (enExample) | ||
| JPS6143112A (ja) | 精神性欲機能障害治療剤 | |
| JP2021527092A5 (enExample) | ||
| JP2006506378A5 (enExample) | ||
| JP2017510607A5 (enExample) | ||
| CN106924378B (zh) | 一种防治和/或治疗慢性唇炎的中草药唇膏 | |
| JP2024500324A5 (enExample) | ||
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| CN104013638B (zh) | 当药黄素及其衍生物的用途 | |
| EP1383495A1 (en) | Duloxetine for treatment of hot flashes | |
| US2761807A (en) | Glycocyamine and methylating agent in vivo creatine producing composition | |
| EP0171227B1 (en) | Use of propiophenone compound | |
| JPH08512311A (ja) | 慢性疲労症候群治療用ヒ素医薬 | |
| CN108703946A (zh) | 一种治疗糖尿病周围神经痛的透皮吸收制剂 | |
| JP7335954B2 (ja) | 白頭翁サポニンｂ４の抗急性痛風性関節炎の医薬における用途 | |
| EP4420660A1 (en) | Use of edaravone in treatment of autism spectrum disorder | |
| JP2021530568A5 (enExample) | ||
| CN114588164B (zh) | 瑞马唑仑在预防围术期低体温和寒战中的应用 | |
| RU2406506C1 (ru) | Фармацевтическая композиция холин альфосцерата в форме раствора для инъекций (холитилин®), обладающая ноотропной активностью и холиномиметическим действием, способ лечения/профилактики заболеваний цнс и последствий черепно-мозговых травм | |
| JP2024531799A5 (enExample) | ||
| JP3253878B2 (ja) | 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法 | |
| EP2727595B1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| CN107260750A (zh) | 人参皂苷Rb1在制备治疗免疫性复发性流产药物中的用途及其药物组合物 | |
| Ravid et al. | The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily: a double-blind, crossover, placebo-controlled study in ambulatory patients | |
| RU2002115814A (ru) | Лечение системной красной волчанки с помощью дегидроэпиандростерона |